Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.
We conducted a prospective study to assess the risk factors, molecular epidemiology and outcome of bloodstream infection (BSI) due to Enterococcus faecium in hospitalized cancer patients. Between 2006 and 2012, a significant increase in vancomycin-susceptible E. faecium BSI was observed among cancer...
Guardado en:
Autores principales: | Carlota Gudiol, Josefina Ayats, Mariana Camoez, M Ángeles Domínguez, Carolina García-Vidal, Marta Bodro, Carmen Ardanuy, Mora Obed, Montserrat Arnan, Maite Antonio, Jordi Carratalà |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1f4e32e78384cb3a4efcc0bda0f8677 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium.
por: Clare L Kinnear, et al.
Publicado: (2020) -
Emergence of Vancomycin-Resistant Enterococcus faecium at an Australian Hospital: A Whole Genome Sequencing Analysis
por: Kelvin W. C. Leong, et al.
Publicado: (2018) -
Enterococcus faecium resistente a vancomicina
por: Marovac B,Jacqueline, et al.
Publicado: (2000) -
Comparison of Enterococcus faecium and Enterococcus faecalis Strains isolated from water and clinical samples: antimicrobial susceptibility and genetic relationships.
por: Gonzalo Castillo-Rojas, et al.
Publicado: (2013) -
RNase 7 contributes to the cutaneous defense against Enterococcus faecium.
por: Bente Köten, et al.
Publicado: (2009)